How far are we in the vaccine race?
Markets and consumers were cheered as Pfizer reported that ithe Covid-19 vaccine candidate its is developing in partnership with BioNTech has an efficacy rate of above 90%. But what do we know about the vaccine? And what does this mean for the vaccine race? Prime Time's Rachel Kelly spoke to Beau No-af-shar, Senior Pharmaceuticals & Healthcare Analyst, Fitch Solutions to find out.
Bring Awedio With You Anywhere, Anytime!
Scan QR code to download our mobile application